awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40672537-E3C2B0F2-5134-4868-9F8D-263BC9E639BA
Q40672537-E3C2B0F2-5134-4868-9F8D-263BC9E639BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40672537-E3C2B0F2-5134-4868-9F8D-263BC9E639BA
Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?
P304
Q40672537-E3C2B0F2-5134-4868-9F8D-263BC9E639BA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40672537-E3C2B0F2-5134-4868-9F8D-263BC9E639BA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc403d3ed86877616e6f054bdca70e1b494f6f03
P304
365-372
http://www.w3.org/2001/XMLSchema#string